Claudin-2 (Cldn2) has been implicated in promoting liver metastasis in breast and colorectal cancers [11,12], while claudin-6 (Cldn6) is associated with chemotherapy resistance and poor prognosis in gastric and cervical adenocarcinomas [13,14]. Here, CLDN6 is linked to colorectal cancer.